Rabbit Anti-COX5B Recombinant Antibody (031) (V2LY-1206-LY871)

Chu, Y. D., Lim, S. N., Yeh, C. T., & Lin, W. R. (2022). COX5B-Mediated Bioenergetic Alterations Modulate Cell Growth and Anticancer Drug Susceptibility by Orchestrating Claudin-2 Expression in Colorectal Cancers. Biomedicines, 10(1), 60.

Shahali, A., Aghaei, N. S. G., Mosharraf, A., Sharestani, S., & Madani, A. (2022). Study of the expression rates of RORA and COX5b genes amongst MS patients compared with healthy individuals as an emerging diagnostic biomarker. Academic Journal of Health Sciencies: Medicina balear, 37(1), 161-165.

Chu, Y. D., Lin, W. R., Lin, Y. H., Kuo, W. H., Tseng, C. J., Lim, S. N., ... & Yeh, C. T. (2020). COX5B-mediated bioenergetic alteration regulates tumor growth and migration by modulating AMPK-UHMK1-ERK cascade in hepatoma. Cancers, 12(6), 1646.

Stein, J., Tenbrock, J., Kristiansen, G., Müller, S. C., & Ellinger, J. (2019). Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma. International Journal of Urology, 26(9), 910-916.

Hinkelbein, J., Böhm, L., Braunecker, S., Adler, C., De Robertis, E., & Cirillo, F. (2017). Decreased tissue COX5B expression and mitochondrial dysfunction during sepsis-induced kidney injury in rats. Oxidative medicine and cellular longevity, 2017.

Hu, T., & Xi, J. (2017). Identification of COX5B as a novel biomarker in high-grade glioma patients. OncoTargets and therapy, 10, 5463.

Gao, S. P., Sun, H. F., Fu, W. Y., Li, L. D., Zhao, Y., Chen, M. T., & Jin, W. (2017). High expression of COX5B is associated with poor prognosis in breast cancer. Future Oncology, 13(19), 1711-1719.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols